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Role of Flippases in Protein Glycosylation in the
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Supplementary Issue: Cellular Anatomy of Lipid Traffic
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ABSTR ACT: Glycosylation is essential to the synthesis, folding, and function of glycoproteins in eukaryotes. Proteins are co- and posttranslationally
modified by a variety of glycans in the endoplasmic reticulum (ER); modifications include C- and O-mannosylation, N-glycosylation, and the addition of
glycosylphosphatidylinositol membrane anchors. Protein glycosylation in the ER of eukaryotes involves enzymatic steps on both the cytosolic and lumenal
surfaces of the ER membrane. The glycans are first assembled as precursor glycolipids, on the cytosolic surface of the ER, which are tethered to the membrane by attachment to a long-chain polyisoprenyl phosphate (dolichol) containing a reduced α-isoprene. The lipid-anchored building blocks then migrate
transversely (flip) across the ER membrane to the lumenal surface, where final assembly of the glycan is completed. This strategy allows the cell to export
high-energy biosynthetic intermediates as lipid-bound glycans, while constraining the glycosyl donors to the site of assembly on the membrane surface. This
review focuses on the flippases that participate in protein glycosylation in the ER.
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Introduction

Eukaryotic cells are subdivided into organelles by lipid
bilayers, with a variety of unique functions and lipid compositions.1 In addition, the lipid components in the plasma
membrane are distributed asymmetrically between the two
monolayers with the aminophospholipids, phosphatidylserine
and phosphatidylethanolamine, located on the cytoplasmic
leaflet, and the choline-containing lipids, sphingomyelin and
phosphatidylcholine, in the exoplasmic leaflet. As the cytoplasmic surface of the endoplasmic reticulum (ER) is the site
of synthesis of the majority of eukaryotic phospholipids, at
least 50% of the newly synthesized phospholipids must flip
to the lumenal monolayer to support the uniform expansion
of the membrane bilayer. The observed final asymmetric distribution of phospholipids in the plasma membrane is the net
result of competing bidirectional, energy-independent flip/
floppases and ATP-requiring, phospholipid pumps catalyzing
the unidirectional transport of phospholipids across the membrane bilayers. Current models suggest that energy-independent flip/floppases mediate the transmembrane movement of
phospholipids in biogenic (self-assembling) membranes, such
as the ER, and the P-type and ATP-binding cassette transporters function to maintain the transbilayer phospholipid
asymmetry in membranes, such as the plasma membrane.2–5
The glycosyl donors employed in protein N-glycosylation,
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C- and O-mannosylation, and glycosylphosphatidylinositol
membrane (GPI) anchoring are assembled on both sides of the
ER membrane and require the participation of the bidirectional, energy-independent class of flippase proteins to enter
the lumen of the ER and participate as glycosyl donors.5–7
While more properly functioning as scramblases, these transporters will be referred to as flippases, but they should not be
confused with the phospholipid flip- and floppases.
Protein N-glycosylation requires the synthesis of a precursor oligosaccharide, containing three glucose (Glc), nine
mannose (Man), and two N-acetyl glucosamine (GlcNAc) residues, attached to a long-chain polyisoprenyl alcohol (dolichol,
Dol) via a diphosphate bridge (Glc 3Man9GlcNAc2-P-P-Dol,
G3-DLO [dolichol-linked oligosaccharide]), as illustrated in
Figure 1.6,8 G3-DLO synthesis is initiated (Step 1, Fig. 1) on
the cytoplasmic leaflet of the ER with the synthesis of a dolichol–diphosphate-linked oligosaccharide intermediate, ManGlcNAc2-P-P-Dol (M5-DLO),9 formed by the sequential
5
addition of sugars to dolichyl phosphate (Dol-P) using UDPGlcNAc (catalyzed by a complex of DPAGT1 and ALG13/14
[asparagine-linked glycosylation])10 and GDP-Man (catalyzed
by a second complex composed of ALG1, ALG2, and
ALG11)11 as glycosyl donors (Step 1, Fig. 1). The M5-DLO
intermediate then migrates (flips) from the cytosolic leaflet of
the ER to the lumenal monolayer (Flippase I, Fig. 1), where
Lipid Insights 2015:8(S1)
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Figure 1. Topological model for DLO synthesis in the ER. M5-DLO (Step 1), Man-P-Dol (Step 2), and Glc-P-Dol (Step 3) are synthesized on the
cytosolic surface of the ER membrane from appropriate sugar-nucleotide donors and Dol-P and diffuse transversely to the lumenal monolayer where
they participate in the synthesis of full-length G3-DLO. The polar head groups of the dolichol-linked intermediates do not spontaneously cross the
ER membrane but are escorted across the highly hydrophobic lipid bilayer by a specialized class of membrane transporters referred to as flippases,
numbered arbitrarily as indicated (Flippase 1: M5-DLO Flippase; Flippase 2: Man-P-Dol Flippase; Flippase 3: Glc-P-Dol Flippase; and Flippase 4: Dol-P
Flippase). The G3 oligosaccharide is transferred to protein nascent chains releasing a molecule of Dol-P-P, which is dephosphorylated by DolPP1; Dol-P
is then returned to the cytosolic monolayer by Flippase 4 (Step 4) for utilization in further rounds of DLO synthesis.

four more Man residues are added using mannosyl phosphoryldolichol (Man-P-Dol) as mannosyl donor and three Glc
residues are added using glucosyl phosphoryldolichol (GlcP-Dol) as glucosyl donor to form the full-length G3-DLO.
Man-P-Dol and Glc-P-Dol are also synthesized on the cytosolic face of the ER membrane, catalyzed by DPM1/2/3 (Step
2, Fig. 1) and ALG5 (Step 3, Fig. 1), respectively. Following synthesis on the cytosolic monolayer, the dolichol-linked
intermediates are flipped to the lumenal monolayer by Flippase 2 and Flippase 3 (Fig. 1), where they function as glycosyl
donors in this pathway. Following en bloc transfer of the precursor oligosaccharide to protein nascent chains, the carrier
lipid, Dol-P-P, is discharged on the lumenal leaflet. Dol-P-P
is dephosphorylated by Dol-P-P phosphatase (DolPP1),12,13 to
form Dol-P, which is then flipped back to the cytosolic monolayer by Flippase 4 (Step 4, Fig. 1), to be reutilized for further
rounds of DLO synthesis.14
46
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Man-P-Dol also provides the mannosyl units for protein C- and O-mannosylation and GPI anchor biosynthesis,
as illustrated in Figure 2.15 Similar to DLO assembly, this
Man-P-Dol is synthesized on the cytosolic surface of the ER
membrane and must be transported to the lumenal monolayer to function as mannosyl donor. Presumably, the Dol-P
molecules released by the mannosyltransferase reactions
are returned to the cytosolic surface for reutilization by the
same mechanism as the Dol-P formed from Dol-P-P and the
Man-P-Dol and Glc-P-Dol mediated reactions in G3-DLO
synthesis on the lumenal leaflet.6
There is substantial evidence supporting the hypothesis that the transbilayer diffusion of the dolichol-linked
intermediates is facilitated by specialized membrane transporters, termed “flippases”. The highly hydrophobic nature of the
inner core of the lipid bilayer presents a substantial biophysical barrier to the spontaneous passage of the hydrophilic head

Protein glycosylation in the endoplasmic reticulum

Figure 2. Man-P-Dol acts as mannosyl donor for the synthesis of M9-DLO, GPI anchors, and C- and O-mannosylated proteins. Man-P-Dol is
synthesized on the cytosolic monolayer of the ER membrane from GDP-Man and Dol-P and flips (Flippase 2) to the lumenal monolayer where it
functions as mannosyl donor for four mannosyltransferases in the DLO pathway and three mannosyltransferases in GPI anchor assembly. At least
seven O-mannosyltransferases have been characterized in yeasts and mammals. The number of C-mannosyltransferases remains unknown. Following
mannosyl transfer, Dol-P is released and returned to the cytosolic monolayer by Flippase 4.

group of the amphipathic dolichol-linked intermediates.5,16–18
Although all of the glycosyltransferases required to assemble
the DLO intermediates have been described, the identities
of the proteins that catalyze the transmembrane movements
of the dolichol-linked intermediates and the precise roles of
two proteins involved in DLO assembly (Lec35 and RFT1)
have not yet been clearly defined.
The description of this enigmatic class of membrane
transporters remains a high priority. It is likely that currently undiagnosed congenital disorders of glycosylation
(CDG)19–24 will be traced to defects in flippases in the protein
glycosylation pathways. CDG is a rapidly expanding family
of genetic diseases attributed to the defective synthesis of glycoproteins and glycolipids, and there are presently over 100
genetic diseases resulting from mutations in glycosylationrelated genes.23 CDG patients present with a wide range of
clinical symptoms varying from relatively mild, with primarily gastrointestinal effects, to very severe, involving multiorgan dysfunctions, skeletal abnormalities, and mental and
psychomotor delay, which often result in embryonic lethality
or infant mortality.21 As many of these disorders are extremely

rare, it is not presently known if the range of clinical symptoms
can be considered diagnostic of a specific disorder or are due
to the leakiness of the defect.20 It is speculative to attempt to
predict the clinical features anticipated from specific flippase
defects; however, some general expectations can be proposed. CDGs arising from defects in Man-P-Dol synthesis
and utilization (DPM1, 2, and 3-CDG and MPDU1-CDG)
appear to be quite severe due to the additive effects on protein
O-mannosylation (a-dystroglycanopathies), GPI anchoring,
and DLO assembly, which would imply that a Man-P-Dol
flippase deficiency would have severe consequences. On the
other hand, defects in Glc-P-Dol utilization (ALG6-CDG
and ALG8-CDG), are much less severe, suggesting that a
defect in Glc-P-Dol flippase might be less severe than the
Man-P-Dol flippase deficiency. M5-DLO flippase deficiency
might be expected to be similar to CDGs involving the early
stages in DLO synthesis (DPAGT1-CDG, ALG13/14CDG, ALG1-CDG, ALG2-CDG, and ALG11-CDG),
which are typically severe. The consequences of the prospective Dol-P recycling flippase are somewhat harder to predict.
Dol-P flippase deficiency may be similar in scope to those
Lipid Insights 2015:8(S1)
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arising from inadequate Dol-P synthesis (DHDDS-CDG,
SRD5A3-CDG, and DK-CDG), and it is possible that deficiencies in Dol-P recycling could be partially alleviated by the
upregulation of Dol-P synthesis de novo.25 It is interesting to
note that a CDG attributed to the recycling DolPP1 has not
yet been reported.
Despite continued keen interest in the putative flippases
of the protein glycosylation pathways of the ER, they
remain undescribed due, primarily, to technical difficulties
inherent in assaying their biochemical activity. Current
analytical approaches are based on localizing a specific DLO
intermediate to one leaflet of the bilayer by using chemical
modification with a membrane-impermeant reagent,5,26,27 or
lectin capture,5,28 or transport of water-soluble analogs containing short isoprenyl chains.29–32 The existing evidence
suggests that the DLO flippases are energy independent and
bidirectional and catalyze an extremely rapid equilibration of
DLO intermediates between the monolayers, with half-times
in the range of a minute or less. These properties, along with the
inherent fragility of transbilayer asymmetry, pose formidable
experimental challenges to using classical biochemical
methodologies. This article reviews the information that is
currently available concerning the flippase activities of the
protein glycosylation pathways of the eukaryotic ER. Results
and observations from some previously unpublished studies
are included. All studies were conducted in accordance with
federal guidelines and approved by the Institutional Animal
Care and Use Committee of the University of Kentucky.

Man-P-Dol Flippase

As noted earlier, Man-P-Dol is synthesized on the cytosolic surface of the ER from GDP-Man and dolichol phosphate by Dpm1 in Saccharomyces cerevisiae and a complex of
three polypeptide subunits (Dpm1, Dpm2, and Dpm3) in
other eukaryotes.15,33 Following synthesis, Man-P-Dol diffuses transversely through the ER membrane to the lumenal
monolayer, where it functions as a mannosyl donor for the
C-mannosylation of tryptophan residues in thrombospondin repeats of cell surface receptors, the O-mannosylation
of serine and threonine units of a-dystroglycan, the addition of four Man residues of the DLO intermediate of the
N-glycosylation pathway, and three (or more) Man units of
GPI anchor intermediates,15,34 as illustrated in Figure 2.
The molecular description of the proteins involved in
the transmembrane diffusion of Man-P-Dol has been a subject of interest for a number of years.35,36 However, due to the
absence of a convenient biochemical assay for Man-P-Dol
flippase activity, progress has been slow. Genetic approaches
have also failed to identify likely flippase candidate proteins, including two recent screens in Hap1 cells (haploid
mammalian cell lines) for defects in GPI assembly. Both of
these screens identified all of the proteins known to participate in GPI formation but failed to identify any proteins that
could plausibly be involved in the transmembrane flipping of
48
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either Man-P-Dol or glucosamine-PI.37,38 There are a number of potential explanations for this observation, including
the possibility, as is true in yeast, that an essential protein is
synthesized by a flippase requiring pathway, in this case an
essential GPI-anchored protein, 39,40 or that multiple genomic
copies of flippase genes are present, making it difficult to eliminate all of the active transcripts. It is possible that flippases
from other pathways possess overlapping substrate specificity,
allowing complementation of the defect by other flippases, or
the flippase activity may reside in a multitasking protein with
another essential function as a second moonlighting activity.41
This final possibility is supported by the recent discovery that
Rhodopsin, in addition to its role as a visual pigment and G
protein-coupled receptor, also functions as an active phospholipid flippase in photoreceptor disc membranes.27,42
Two strategies for the in vitro measurement of Man-P-Dol
flippase activity have been developed. One approach, relies on
the use of a water-soluble version of Man-P-Dol containing
citronellyl phosphate (Cit-P), a short-chain analog of Dol-P
with a 10 carbon isoprenyl chain and a saturated α-isoprene.
This assay relies on the assumption that recognition of the
polar head group and its movement across the bilayer are the
most critical aspects of the flipping process and measures
Man-P-Dol flipping as a simple transport process into sealed
rat liver ER vesicles.29,32,43 This is a variation of the approach
used by Bishop and Bell to assay flip-flopping of phosphatidylcholine in ER vesicles.44
The selection of Man-P-Cit as an appropriate analog for
Man-P-Dol is strongly supported by the observation that ManP-Cit is a suitable substrate for all the Man-P-Dol-mediated
mannosyltransferases in the DLO pathway45 and in GPI
assembly,46 in O-mannosylation,47 and in C-mannosylation
(J. S. Rush, C. J. Waechter, and J. Hofsteenge, 2008, unpublished observation). Furthermore, Man-P-Cit was able to
allosterically stimulate GlcNAc-P-P-Dol synthesis,48 similar to
native Man-P-Dol, and was able to cross the ER membrane and
function as a mannosyl donor in streptolysin-O-permeabilized
Lec35 cells under conditions in which the Man-P-Dol utilization defect was preserved.34 Lec35 cells exhibit a defect in
Man-P-Dol and Glc-P-Dol utilization that, apparently, does
not involve dolichol-intermediate flipping.34
Man-P-Cit is transported into the lumen of intact rat liver
ER vesicles by a process that is time dependent, reversible, saturable, protease sensitive, stereoselective, enriched in the ER,
sensitive to incubation with diethylpyrocarbonate (DEPC),
and energy independent.29 The activity was not observed in
intact erythrocytes or synthetic liposomes29 but was observed
in proteoliposomes reconstituted from octyl glucoside and Triton X-100 soluble detergent extracts of rat liver ER membrane
proteins.43 Furthermore, the soluble detergent extracts could
be fractionated by ion exchange and partially purified.43 It is
observed that when Man-P-Cit uptake in intact rat liver ER
vesicles is measured over a range of temperatures, an Arrhenius plot of the rate of transport reveals an inflection point
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at ~16°C, correlating exactly with a corresponding inflection point in the rate of increase in the incorporation of [3H]
mannose units into [3H]Man6–9-DLO from GDP-[3H]Man
(which requires the participation of [3H]Man-P-Dol as an
intermediate), performed in a parallel incubation (J. S. Rush
and C. J. Waechter, 2007, unpublished observation). In this
experiment, the increase in the initial rate of incorporation
of [3H]mannose into [3H]Man-P-Dol is linear with respect
to temperature, as would be anticipated for a process occurring on only one side of the membrane bilayer. This observation is consistent with Man-P-Cit uptake and Man-P-Dol
flipping occurring by a transport process, which is affected
similarly by membrane fluidity and supports the conclusion
that Man-P-Cit transport accurately reflects flippase activity.
An alternative approach utilized native [3H]Man-P-Dol
symmetrically reconstituted into sealed synthetic proteoliposomes and a membrane-impermeant oxidant (carboxy-2,2,6,6tetramethylpiperidine 1-oxyl NO+) to selectively modify the
[3H]Man-P-Dol molecules located in the outer monolayer of
the synthetic vesicles.5,26 In this method, 50% of the [3H]ManP-Dol in phospholipid vesicles lacking an active flippase will be
oxidized. The remaining 50% is sequestered within the inner
monolayer of the vesicle and is protected from reaction with the
oxidant. However, in vesicles equipped with an active flippase,
the [3H]Man-P-Dol facing the lumen of the proteoliposome is
able to equilibrate into the outer monolayer and be oxidized.
The result is that a larger fraction of the [3H]Man-P-Dol will be
subject to oxidation. This study demonstrated rapid transbilayer
movement of Man-P-Dol that is protein dependent, energy
independent, DEPC sensitive, and highly specific for both the
anomeric configuration of Man and a reduced a-isoprene unit.26
Further studies showed that Man-P-Dol flippase activity
could be resolved from flippase activities that mediate the
transmembrane movements of M5-DLO (see Man5GlcNAc2P-P-Dol flippase section) and glycerophospholipid flippase
by concanavalin A (ConA) affinity and ion-exchange
chromatography.26 Limiting dilution of these detergentsoluble extracts into phospholipid vesicles leads to the conclusion that the Man-P-Dol flippase constitutes ~1% of the
proteins in the detergent extract.26
Flippase assays based on water-soluble analog transport
have the advantages of simplicity and rapidity and allow nearinitial rate estimations in the absence of detergents.29,32 The
alternative method employing full-length Man-P-Dol avoids
potential concerns arising from the use of structural analogs,5,26 but relies on the reconstitution of detergent-solubilized
membrane preparations, and is potentially limited by the time
constraint imposed by reaction with the mannolipid, which
may significantly exceed the extremely rapid time course of
transmembrane diffusion, even at 0°C (t , 7 minutes).5,26 In
this regard, it is important to note that the properties of the
Man-P-Cit transport activity in rat liver ER vesicles were identical to the activity reconstituted from detergent extracts, so the
probability that some essential intrinsic property of the flippase

system is affected by detergent solubilization and reconstitution is very low. Although neither method has yet yielded a
full molecular description of the Man-P-Dol flippase proteins,
some preliminary properties have been identified and it is
reassuring that the apparent properties of the flippase protein
determined by the two methods are very similar. The complementary analytical methods identify an activity that is energy
independent, bidirectional, stereoselective, sensitive to proteolysis and protein alkylation by DEPC and NEM, and amenable
to fractionation by a variety of chromatographic approaches.

Glc-P-Dol Flippase

Glc-P-Dol is synthesized by Glc-P-Dol synthase (ALG5)
using UDP-Glc as glucosyl donor and Dol-P as the lipid
acceptor on the cytosolic surface of the ER but functions as
a glucosyl donor in the synthesis of G3-DLO on the lumenal monolayer.49,50 The topological reorientation of Glc-P-Dol
has been studied in sealed, ER-enriched microsomal vesicles
from pig brain and rat liver by following the transport of a
water-soluble Glc-P-Dol analog, Glc-P-citronellol (Glc-PCit).30 Similar to the properties of the Man-P-Dol flippase
reported earlier, Glc-P-Cit uptake in rat liver ER vesicles is
time dependent, saturable, bidirectional, trypsin sensitive,
and completely dependent on an intact permeability barrier.
Furthermore, Glc-P-Cit is not taken up by synthetic liposomes or erythrocytes and Glc-P-Cit transport activity fractionates with heavy microsomes (ER-enriched) in brain. 30
The molecular description of the Glc-P-Dol flippase protein
remains a high priority, as severely affected human patients
with CDG attributable to defects in the enzymes that catalyze
attachment of Glc units to the DLO intermediate (ALG6 and
ALG8) have been identified and genetic defects in Glc-P-Dol
flipping would be expected to have similar pathologies.51

Man5GlcNAc2-P-P-Dol Flippase

M5-DLO is synthesized from Dol-P, UDP-GlcNAc, and
GDP-Man on the cytosolic surface of the ER (Fig. 1) by two
multienzyme complexes, consisting of DPAGT1, ALG13,
and ALG14 that form GlcNAc 2-P-P-Dol10 and ALG1,
ALG2, and ALG11 that add one b-mannosyl and four
a-mannosyl units to form M5-DLO.11 The transmembrane
diffusion of the M5-DLO intermediate is particularly interesting due to the presumed difficulty involved in the passage
of this large, extremely hydrophilic head group through the
hydrophobic core of the ER membrane. 28,52,53 The identification of the yeast RFT1 protein as a candidate M5-DLO
flippase, primarily based on genetic evidence by Helenius et al, was an exciting development.54 RFT1-depleted
yeast cells accumulate large quantities of M5-DLO and are
severely defective in protein N-glycosylation despite possessing normal levels of Man-P-Dol synthase and no apparent
defect in the Man-P-Dol: M5-DLO mannosyltransferases
(ALG3, ALG9, and ALG12).54 However, direct biochemical assay of M5-DLO flippase activity by two independent
Lipid Insights 2015:8(S1)
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methods indicates that although RFT1 is clearly required for
proper assembly of the full-length DLO intermediate, it is
dispensable for M5-DLO flipping in vitro.28,55–57
M5-DLO flipping has been measured directly in
reconstituted proteoliposomes, employing a ConA binding
assay.26,28,55,56 In this assay, proteoliposomes are reconstituted
from Triton X-100 soluble cellular extracts and exogenous
phospholipids with traces of [3H]M5-DLO equally distributed between the two monolayers. When incubated with soluble ConA, the radiolabeled DLO in the outer leaflet of the
proteoliposome is bound by ConA and cannot be extracted
into organic solvent, whereas since ConA cannot spontaneously cross the membrane bilayer, the DLO in the inner leaflet
is sequestered from the ConA and, as a result, is fully extractable. Ideally, in proteoliposomes lacking an active flippase,
only 50% of the [3H]M5-DLO is extractable. In proteoliposomes containing an active flippase, unbound M5-DLO is able
to equilibrate with the outer monolayer and become bound by
ConA. Consequently, a smaller fraction of the intermediate is
extractable in liposomes containing a flippase activity. Using
this assay, M5-DLO flipping was shown to be extremely
rapid (a rate constant of . 2 × 10 -3 s-1), protein dependent,
energy independent, bidirectional, and protease sensitive.
Significantly, the M5-DLO flippase activity could be resolved
from an unrelated phospholipid flippase activity by several
chromatographic methods.56 Furthermore, the M5-DLO
flippase activity preferred the natural M5-DLO isomer over a
catabolic M5-DLO intermediate, with an alternative branching pattern, and a biosynthetic M7-DLO intermediate demonstrating a high degree of substrate specificity.56 A further
report showed that M5-DLO flipping was inhibited by the
inclusion of GlcNAc2-P-P-Cit, a water-soluble M5-DLO
analog, and that whereas M5-DLO was rapidly flipped with
a time constant t , 2 minutes, the triantennary intermediate
M3-DLO flipped much more slowly with t , 200 minutes.
DLOs larger than M5-DLO also flipped slowly with t values
ranging from 10 to . 200 minutes.28 Importantly, this activity
was present in Triton X-100 soluble extracts derived from cells
in which RFT1 had been depleted and was not immunoprecipitated with specific antibody to epitope-tagged RFT1.28,55
In addition, M5-DLO flippase activity could be resolved from
the epitope-tagged RFT1 protein by velocity sedimentation,
ion-exchange, and blue dye resin chromatography. 28,55
In another set of studies, sealed ER vesicles from
RFT1-depleted yeast cells were fully capable of elongating
[3H]GlcNAc2-P-P-Dol, synthesized in situ, to form [3H]
M9-DLO in vitro when incubated with nonradioactive GDPMan.57 As this elongation reaction cannot occur without
translocation of the DLO intermediate to the lumenal compartment, this is strong evidence that the RFT1-depleted
microsomes are still capable of flipping M5-DLO. GlcNAc2P-P-Dol has been shown to be flipped, presumably by the
M5-DLO flippase in microsomes from a variety of tissues and
yeasts.58–63 To measure M5-DLO flipping directly in sealed
50
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yeast ER vesicles, the transport of [3H]GlcNAc2-P-P-Dol15,
a water-soluble analog of GlcNAc2-P-P-Dol with a 15-carbon
a-reduced isoprenol chain, was measured. RFT1-depleted,
ER-enriched yeast microsomes transported water-soluble
[3H]GlcNAc2-P-P-Dol15 into the lumen of the sealed vesicles
at an even faster rate than intact vesicles from undepeleted
cells.57 Furthermore, when the sealed RFT1-depleted microsomal vesicles were incubated with a membrane-permeant
N-glycosylation acceptor peptide and [3H]GlcNAc2-P-P-Dol15,
the peptide was glycosylated with [3H]GlcNAc2, presumably
by the lumenal oligosaccharyltransferase (OST), demonstrating that the water-soluble analog has access to the lumenal
compartment.57 Finally, in an indirect assay for the recycling of
Dol-P,14 it is observed that when sealed RFT1-depleted yeast
microsomal vesicles are incubated with a membrane-permeant
N-glycosylation acceptor peptide, a very large amount of newly
formed Dol-P is generated (J. S. Rush and C. J. Waechter,
2008, unpublished observation). This assay was previously used
to successfully establish the biochemical mechanism, by which
Dol-P derived from Dol-P-P, generated by the N-glycosylation
reaction, is returned to the cytosolic monolayer for further
rounds of DLO synthesis14 and is strong evidence that a large
portion of the accumulated M5-DLO can enter the lumen of
the ER in vesicles prepared from RFT1-depleted cells and
become accessible to OST.
This biochemical evidence strongly suggests that RFT1
is not an essential subunit of the M5-DLO flippase in ER
vesicles isolated from disrupted cells. Recently, this conclusion has been further supported by the observation that
mutant Trypanosoma brucei cells lacking RFT1 are viable and
N-glycosylate protein normally despite accumulating a large
amount of M5-DLO.64 The exact role of RFT1 in the synthesis of full-length DLOs in vivo and the identity of the
M5-DLO flippase remain to be elucidated, but RFT1’s role
may be similar to that of the CHO Lec35 protein (MPDU1),
which appears to be required for the utilization of both ManP-Dol and Glc-P-Dol, in vivo, but is dispensable in vitro.34

Dol-P Flippase

Dol-P is formed on the lumenal surface of the ER membrane
from several biosynthetic processes, including (1) cleavage
of Dol-P-P generated during the OST reaction of protein
N-glycosylation, (2) the three glucosyltransferase reactions
utilizing Glc-P-Dol, and (3) by all of the Man-P-Dol-mediated
mannosyltransferase reactions (the four DLO mannosyltransferases, the three GPI anchor mannosyltransferases and Cand O-mannosylation; see Fig. 2) utilizing Man-P-Dol as
mannosyl donor.6,14 This lumenally oriented Dol-P must be
returned to the cytosolic surface of the ER in order to participate in further rounds of glycan synthesis. The recycling of
Dol-P substantially contributes to the maintenance of biologically relevant rates of protein N-glycosylation, as a significant
reduction of glycosylation is observed in the yeast DolPP1
mutant, CWH8, even though this mutation presumably

Protein glycosylation in the endoplasmic reticulum

Figure 3. Transport of 32P-Cit into the lumen of intact rat liver ER vesicles. Panel A, open circle (○), 32P-Cit was incubated with sealed rat liver ER vesicles
at 22°C for the indicated periods of time. Following incubation, the transport reactions were diluted with 0.5 mL ice-cold buffer (10 mM Tris-CL, pH 7.4,
0.25 M sucrose) and filtered through a Millipore 0.45 µm HA filter. The filters were washed with an additional 10 mL ice-cold buffer and assayed for
radioactivity, as described earlier. 29 Panel A, closed circle (), sealed rat liver ER vesicles were pre-incubated with 32P-Cit for 10 minutes and diluted
with 0.5 mL, 10 mM Tris-Cl, pH 7.4, and 0.25 M sucrose all at 22°C. At the indicated times, the diluted reactions were filtered through a 0.45 µm HA
filter, washed with an additional 10 mL ice-cold buffer, and assayed for radioactivity. Panel B, large unilamellar synthetic phospholipid vesicles were
reconstituted from octyl glucoside soluble phospholipids in the presence of 32P-Cit, as described elsewhere.43,67 The vesicles containing 32P-Cit entrapped
in the lumen were incubated with 10 mM Tris-Cl, pH 7.4, and 0.25 M sucrose at 22°C for the indicated periods of time and chromatographed on a 30 mL
column of Sephadex G-50 equilibrated in 10 mM Tris-Cl, pH 7.4, and 0.25 M sucrose. Fractions of 1 mL were collected and monitored for radioactivity by
scintillation spectrometry. The percentage of the radioactivity eluting in the void volume of the column is plotted versus time of incubation.

affects only the recycling of Dol-P from DLO and not the
substantial number of Dol-P molecules arising from the other
glycosyltransferase reactions.14 Despite the clear significance
of the recycling of the lipid anchor, the molecular and biochemical details of this process remain virtually unknown. It
will be worth exploring the possibility that CWH8 (DolPP1)
plays a role in the translocation of Dol-P back to the cytosolic
surface of the ER.
Presumably, Dol-P is returned to the cytoplasmic
monolayer by a flippase-mediated process, as the amphipathic lipid anchor is unable to spontaneously cross the hydrophobic interior of the membrane bilayer. However, the
identity of this flippase has not been established. Indeed, it
is not known if multiple, unique flippases are associated with
the various glycosyltransferases and the DolPP1 involved in
the production of lumenal Dol-P mentioned earlier. A membrane-associated activity that transports Cit-32P (a watersoluble analog of Dol-P) into the lumen of sealed vesicles has
been detected (J. S. Rush and C. J. Waechter, 2006, unpublished observation), as shown in Figure 3. When sealed rat
liver ER vesicles are incubated with Cit-32P, the analog is
rapidly transported into the lumen of the vesicle with an
apparent half-time of uptake of ~23 seconds (Fig. 3, panel
A). When the ER vesicles are first loaded with Cit-32P by
preincubation and then diluted into isotonic buffer at room
temperature, the internalized Cit-32P effluxes from the vesicles with a half-time of exit of ~30 seconds, showing that the
uptake process is fully reversible (Fig. 3, panel A). Cit-32P
does not spontaneously leak out of protein-free phospholipid

vesicles, as shown in Figure 3, panel B (half-time of exit ~94
hours). Preliminary studies indicate that as with the other
ER-associated flippase activities, this activity is membrane
protein dependent, time dependent, protease sensitive, and
energy independent (J. S. Rush and C. J. Waechter, 2006,
unpublished observation). The identity of the protein mediating the return of Dol-P to the cytosolic monolayer has not
yet been determined, but recycling by an antiport mechanism via one of the other flippase activities seems unlikely,
as Cit-P does not have any appreciable effect on the uptake
or efflux of any of the other water-soluble analogs employed
in flippase assays.

Concluding Comments

The transbilayer diffusion of Man-P-Dol in the ER membrane was first investigated by Haselbeck and Tanner using
an elegant enzyme-coupled assay over 40 years ago.35,36
Despite continued interest in the mechanism of Man-P-Dol
flipping in the ER, the proteins that participate in this essential step involved in C- and O-mannosylation, DLO synthesis, and GPI anchor formation in the ER remain unidentified.
The fragility of the topological asymmetry of the lipid bilayer
and the apparent physical properties of the putative flippases have presented substantial experimental difficulties
to the direct measurement of flippase activity in vitro. The
biochemical assays reviewed here are important advances
and have led to the identification of a number of physical
properties of the prospective flippases. In common with the
glycerophospholipid flippases present in biogenic membranes,
Lipid Insights 2015:8(S1)
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the ER dolichol-intermediate flippases are bidirectional and
energy independent and catalyze an extremely rapid reequilibration of the intermediates between the two monolayers.
Hypothetical models for flippase action have been proposed
by Kol et al,65 Sanyal and Menon,5,26 and Ernst and Menon.66
It is possible that the translocation events are energy independent for lipid intermediates because the flipping is driven
by mass action, as the intermediates are rapidly utilized at
the lumenal sites. It is also reassuring that although the
experimental approaches employed in these assays differ significantly, the individual studies identify very similar physical properties, which are also consistent with observations
from coupled in vitro enzymatic systems. The development
of reliable methods for the solubilization, fractionation, and
functional reconstitution of the flippase activities coupled
to proteomic approaches paves the way for the purification,
identification, and characterization of these final undescribed
steps in protein glycosylation in the ER.
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